Authors: FANDI A TAAMMA A AZLI N BACHOUCHI M YANES B ARMAND JP CVITKOVIC E

Citation: A. Fandi et al., PALLIATIVE TREATMENT WITH LOW-DOSE CONTINUOUS-INFUSION 5-FLUOROURACILIN RECURRENT AND OR METASTATIC UNDIFFERENTIATED NASOPHARYNGEAL CARCINOMA TYPE/, Head & neck, 19(1), 1997, pp. 41-47

Authors: CVITKOVIC E ESCHWEGE F RAHAL M",DOSEN,"MERSIC Z KRAJINA Z ARMAND JP BOUHRIS J TUBIANAMATHIEU M FOUNTZILAS G KOSMIDIS PA PRASAD U GANESAN S ELGUEDDARI B BACHOUCHI M MANSOURI A OLIVEIRA J RAPOSO J WIERZBICKI R LIANES P PENA C ONAT H ALTUN M BENHAMOU E DUCOURTIEUX M AZLI N FANDI A TAAMMA A BOSQ J KLIJANIENKO J SIGAL R HONG WK VOKES EE CLARK JR LEFLOCH O BERNIER J

Citation: E. Cvitkovic et al., PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL COMPARING NEOADJUVANT CHEMOTHERAPY (CISPLATIN, EPIRUBICIN, BLEOMYCIN) PLUS RADIOTHERAPY VS RADIOTHERAPY ALONE IN STAGE-IV (GREATER-THAN-OR-EQUAL-TO-N2, M0) UNDIFFERENTIATED NASOPHARYNGEAL CARCINOMA - A POSITIVE EFFECT ON PROGRESSION-FREESURVIVAL, International journal of radiation oncology, biology, physics, 35(3), 1996, pp. 463-469

Authors: FANDI A TAAMMA A AZLI N BACHOUCHI M YANES B CVITKOVIC E ARMAND J

Citation: A. Fandi et al., 5-FLUOROURACIL (FU) BLEOMYCIN (B), EPIRUBICIN (E), CISPLATIN (P) IN LOCALLY ADVANCED (LA), RECURRENT AND OR IMETASTATIC (REC/MTS) UNDIFFERENTIATED CARCINOMA NASOPHARYNGEAL TYPE (UNCT) PRELIMINARY ACTIVITY TOXICITY REPORT/, European journal of cancer, 31A, 1995, pp. 401-401

Authors: CVITKOVIC E BACHOUCHI M BOUSSEN H BUSSON P ROUSSELET G MAHJOUBI R FLORES P TURSZ T ARMAND JP AZLI N

Citation: E. Cvitkovic et al., LEUKEMOID REACTION, BONE-MARROW INVASION, FEVER OF UNKNOWN ORIGIN, AND METASTATIC PATTERN IN THE NATURAL-HISTORY OF ADVANCED UNDIFFERENTIATED CARCINOMA OF NASOPHARYNGEAL TYPE - A REVIEW OF 255 CONSECUTIVE CASES, Journal of clinical oncology, 11(12), 1993, pp. 2434-2442

Authors: ROUSSELET G BACHOUCHI M BUSSON P DEVATHAIRE F WAKASUGI H SCHWAAB G AZLI N ARMAND JP CVITKOVIC E TURSZ T

Citation: G. Rousselet et al., CLINICAL IMPLICATIONS OF THE SERUM LEVEL OF CD23 IN PATIENTS WITH UNDIFFERENTIATED NASOPHARYNGEAL CARCINOMA, Journal of clinical oncology, 11(11), 1993, pp. 2143-2149

Authors: GUILLOT T SPIELMANN M KAC J LUBOINSKI B TELLEZBERNAL E MUNCK JN BACHOUCHI M ARMAND JP CVITKOVIC E

Citation: T. Guillot et al., NEOADJUVANT CHEMOTHERAPY IN MULTIPLE SYNCHRONOUS HEAD AND NECK AND ESOPHAGUS SQUAMOUS-CELL CARCINOMAS, The Laryngoscope, 102(3), 1992, pp. 311-319